Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma

L. Haertle, N. Buenache, HN. Cuesta Hernández, M. Simicek, R. Snaurova, I. Rapado, N. Martinez, N. López-Muñoz, JM. Sánchez-Pina, U. Munawar, S. Han, Y. Ruiz-Heredia, R. Colmenares, M. Gallardo, M. Sanchez-Beato, MA. Piris, MK. Samur, NC. Munshi,...

. 2023 ; 15 (2) : . [pub] 20230115

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003153

Grantová podpora
P50 CA100707 NCI NIH HHS - United States

For the treatment of Multiple Myeloma, proteasome inhibitors are highly efficient and widely used, but resistance is a major obstacle to successful therapy. Several underlying mechanisms have been proposed but were only reported for a minority of resistant patients. The proteasome is a large and complex machinery. Here, we focus on the AAA ATPases of the 19S proteasome regulator (PSMC1-6) and their implication in PI resistance. As an example of cancer evolution and the acquisition of resistance, we conducted an in-depth analysis of an index patient by applying FISH, WES, and immunoglobulin-rearrangement sequencing in serial samples, starting from MGUS to newly diagnosed Multiple Myeloma to a PI-resistant relapse. The WES analysis uncovered an acquired PSMC2 Y429S mutation at the relapse after intensive bortezomib-containing therapy, which was functionally confirmed to mediate PI resistance. A meta-analysis comprising 1499 newly diagnosed and 447 progressed patients revealed a total of 36 SNVs over all six PSMC genes that were structurally accumulated in regulatory sites for activity such as the ADP/ATP binding pocket. Other alterations impact the interaction between different PSMC subunits or the intrinsic conformation of an individual subunit, consequently affecting the folding and function of the complex. Interestingly, several mutations were clustered in the central channel of the ATPase ring, where the unfolded substrates enter the 20S core. Our results indicate that PSMC SNVs play a role in PI resistance in MM.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003153
003      
CZ-PrNML
005      
20230421095926.0
007      
ta
008      
230413s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers15020532 $2 doi
035    __
$a (PubMed)36672481
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Haertle, Larissa $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain $u Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany $1 https://orcid.org/0000000239279163
245    10
$a Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma / $c L. Haertle, N. Buenache, HN. Cuesta Hernández, M. Simicek, R. Snaurova, I. Rapado, N. Martinez, N. López-Muñoz, JM. Sánchez-Pina, U. Munawar, S. Han, Y. Ruiz-Heredia, R. Colmenares, M. Gallardo, M. Sanchez-Beato, MA. Piris, MK. Samur, NC. Munshi, R. Ayala, KM. Kortüm, S. Barrio, J. Martínez-López
520    9_
$a For the treatment of Multiple Myeloma, proteasome inhibitors are highly efficient and widely used, but resistance is a major obstacle to successful therapy. Several underlying mechanisms have been proposed but were only reported for a minority of resistant patients. The proteasome is a large and complex machinery. Here, we focus on the AAA ATPases of the 19S proteasome regulator (PSMC1-6) and their implication in PI resistance. As an example of cancer evolution and the acquisition of resistance, we conducted an in-depth analysis of an index patient by applying FISH, WES, and immunoglobulin-rearrangement sequencing in serial samples, starting from MGUS to newly diagnosed Multiple Myeloma to a PI-resistant relapse. The WES analysis uncovered an acquired PSMC2 Y429S mutation at the relapse after intensive bortezomib-containing therapy, which was functionally confirmed to mediate PI resistance. A meta-analysis comprising 1499 newly diagnosed and 447 progressed patients revealed a total of 36 SNVs over all six PSMC genes that were structurally accumulated in regulatory sites for activity such as the ADP/ATP binding pocket. Other alterations impact the interaction between different PSMC subunits or the intrinsic conformation of an individual subunit, consequently affecting the folding and function of the complex. Interestingly, several mutations were clustered in the central channel of the ATPase ring, where the unfolded substrates enter the 20S core. Our results indicate that PSMC SNVs play a role in PI resistance in MM.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Buenache, Natalia $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain
700    1_
$a Cuesta Hernández, Hipólito Nicolás $u Kinases, Protein Phosphorylation and Cancer, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain
700    1_
$a Simicek, Michal $u Haematology, Ostrava University Hospital, 70300 Ostrava, Czech Republic $u Faculty of Medizine, Ostrava University, 70300 Ostrava, Czech Republic $1 https://orcid.org/0000000323882723 $7 xx0247832
700    1_
$a Snaurova, Renata $u Haematology, Ostrava University Hospital, 70300 Ostrava, Czech Republic $u Faculty of Medizine, Ostrava University, 70300 Ostrava, Czech Republic
700    1_
$a Rapado, Inmaculada $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain
700    1_
$a Martinez, Nerea $u Centro de Investigación Biomédica en Red (CIBER) de Cáncer (CIBERONC), 28029 Madrid, Spain $u Departamento Hematopatología Translacional, IDIVAL, Instituto de Investigación Marqués de Valdecilla, 39011 Santander, Spain
700    1_
$a López-Muñoz, Nieves $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain
700    1_
$a Sánchez-Pina, José María $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain
700    1_
$a Munawar, Umair $u Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany
700    1_
$a Han, Seungbin $u Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany $1 https://orcid.org/0000000311173102
700    1_
$a Ruiz-Heredia, Yanira $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain $u Altum Sequencing Co., 28005 Madrid, Spain $1 https://orcid.org/0000000298952100
700    1_
$a Colmenares, Rafael $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain $1 https://orcid.org/000000025761886X
700    1_
$a Gallardo, Miguel $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain $1 https://orcid.org/0000000236999130
700    1_
$a Sanchez-Beato, Margarita $u Centro de Investigación Biomédica en Red (CIBER) de Cáncer (CIBERONC), 28029 Madrid, Spain $u Medical Oncology Department, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, 28220 Madrid, Spain $1 https://orcid.org/0000000200587599
700    1_
$a Piris, Miguel Angel $u Centro de Investigación Biomédica en Red (CIBER) de Cáncer (CIBERONC), 28029 Madrid, Spain $u Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, 28040 Madrid, Spain $1 https://orcid.org/0000000158393634
700    1_
$a Samur, Mehmet Kemal $u Department of Data Science, Dana Farber Cancer Institute, Boston, MA 02215, USA $u Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA
700    1_
$a Munshi, Nikhil C $u Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA $u VA Boston Healthcare System, Boston, MA 02115, USA
700    1_
$a Ayala, Rosa $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain $u Altum Sequencing Co., 28005 Madrid, Spain $1 https://orcid.org/0000000226998353
700    1_
$a Kortüm, Klaus Martin $u Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany $1 https://orcid.org/0000000270110286
700    1_
$a Barrio, Santiago $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain $u Altum Sequencing Co., 28005 Madrid, Spain
700    1_
$a Martínez-López, Joaquín $u Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain $u Altum Sequencing Co., 28005 Madrid, Spain $1 https://orcid.org/0000000179080063
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 15, č. 2 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36672481 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421095918 $b ABA008
999    __
$a ok $b bmc $g 1922793 $s 1189360
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 2 $e 20230115 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
GRA    __
$a P50 CA100707 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20230413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace